David Larsen
Stock Analyst at BTIG
(0.09)
# 4,275
Out of 4,334 analysts
563
Total ratings
33.8%
Success rate
-6.9%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Downgraded: Hold | n/a | $19.94 | - | 12 | May 14, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | n/a | $1.29 | - | 25 | May 12, 2026 | |
| DCGO DocGo | Maintained: Hold | n/a | $0.6305 | - | 18 | May 12, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 | $24.88 | +20.58% | 18 | May 11, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | n/a | $0.8522 | - | 8 | May 11, 2026 | |
| LFST LifeStance Health Group | Maintained: Buy | $11 → $12 | $7.39 | +62.38% | 5 | May 8, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $10 | $4.19 | +138.66% | 43 | May 7, 2026 | |
| TOI The Oncology Institute | Maintained: Buy | $7 | $4.59 | +52.51% | 9 | May 7, 2026 | |
| MDLN Medline | Maintained: Buy | $55 | $37.01 | +48.61% | 4 | May 7, 2026 | |
| HSIC Henry Schein | Maintained: Hold | n/a | $74.21 | - | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $17 | $14.00 | +21.43% | 30 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.96 | - | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $65 | $58.50 | +11.11% | 16 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.57 | - | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $44.41 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $88.11 | +24.84% | 29 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.75 | - | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $160.17 | +112.27% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $37.85 | +5.68% | 13 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.95 | +102.53% | 50 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $40 | $28.18 | +41.97% | 11 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $167.90 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.37 | - | 17 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.20 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $86.39 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $22.79 | n/a | 15 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $274.91 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $160.30 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $93.26 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $200.68 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $9 | $2.83 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $766.08 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.75 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 → $25 | $25.94 | n/a | 5 | Nov 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
Doximity
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $19.94
Upside: -
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.29
Upside: -
DocGo
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.6305
Upside: -
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $24.88
Upside: +20.58%
Definitive Healthcare
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $0.8522
Upside: -
LifeStance Health Group
May 8, 2026
Maintained: Buy
Price Target: $11 → $12
Current: $7.39
Upside: +62.38%
LifeMD
May 7, 2026
Reiterated: Buy
Price Target: $10
Current: $4.19
Upside: +138.66%
The Oncology Institute
May 7, 2026
Maintained: Buy
Price Target: $7
Current: $4.59
Upside: +52.51%
Medline
May 7, 2026
Maintained: Buy
Price Target: $55
Current: $37.01
Upside: +48.61%
Henry Schein
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $74.21
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $14.00
Upside: +21.43%
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $7.96
Upside: -
May 4, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $58.50
Upside: +11.11%
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $6.57
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $44.41
Upside: -
Mar 18, 2026
Maintained: Buy
Price Target: $110
Current: $88.11
Upside: +24.84%
Mar 5, 2026
Maintained: Hold
Price Target: n/a
Current: $23.75
Upside: -
Mar 4, 2026
Maintained: Buy
Price Target: $340
Current: $160.17
Upside: +112.27%
Mar 2, 2026
Maintained: Buy
Price Target: $40
Current: $37.85
Upside: +5.68%
Feb 25, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $3.95
Upside: +102.53%
Feb 17, 2026
Maintained: Buy
Price Target: $37 → $40
Current: $28.18
Upside: +41.97%
Feb 5, 2026
Maintained: Hold
Price Target: n/a
Current: $167.90
Upside: -
Jan 22, 2026
Maintained: Hold
Price Target: n/a
Current: $15.37
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $13.20
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $86.39
Upside: -
Mar 5, 2025
Maintained: Buy
Price Target: $35
Current: $22.79
Upside: n/a
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $274.91
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $160.30
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $93.26
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $200.68
Upside: n/a
Oct 31, 2018
Maintained: Hold
Price Target: $17 → $9
Current: $2.83
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $766.08
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.75
Upside: n/a
Nov 4, 2016
Maintained: Hold
Price Target: $26 → $25
Current: $25.94
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a